Simonetta Bisanzi
Overview
Explore the profile of Simonetta Bisanzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Marco L, Bisanzi S, Ronco G, Mancuso P, Carozzi F, Allia E, et al.
Microbiol Spectr
. 2024 Nov;
13(1):e0089724.
PMID: 39576120
Importance: Large randomized clinical trials have demonstrated that human papillomavirus (HPV) testing for high-risk types is more effective than cytology in detecting pre-cancerous lesions and preventing cervical cancer. Its use...
2.
Bisanzi S, Puliti D, Picozzi G, Romei C, Pistelli F, Deliperi A, et al.
Cancers (Basel)
. 2024 Jun;
16(12).
PMID: 38927981
The role of total plasma cell-free DNA (cfDNA) in lung cancer (LC) screening with low-dose computed tomography (LDCT) is uncertain. We hypothesized that cfDNA could support differentiation between malignant and...
3.
Benevolo M, Ronco G, Mancuso P, Carozzi F, De Marco L, Allia E, et al.
EBioMedicine
. 2024 May;
104:105149.
PMID: 38759278
Background: Each high-risk HPV genotype has different oncogenic potential, and the risk of CIN3+ varies according to genotype. We evaluated the performance of different strategies of HPV-positivity triage combining cytology,...
4.
Russo V, Tamburrino L, Morselli S, Sani C, Baldi E, Sebastianelli A, et al.
Prostate Cancer Prostatic Dis
. 2024 Feb;
28(1):202-209.
PMID: 38402304
Background: Hyperglycemia can promote the development of prostate cancer (PCa). Differential expression levels of miRNAs between PCa patients and controls were also reported. Therefore, we examined the relationship between hyperglycemia...
5.
Scebba F, Salvadori S, Cateni S, Mantellini P, Carozzi F, Bisanzi S, et al.
Int J Mol Sci
. 2023 Nov;
24(21).
PMID: 37958700
Ovarian cancer (OC) is the most lethal of all gynecological cancers. Due to vague symptoms, OC is mostly detected at advanced stages, with a 5-year survival rate (SR) of only...
6.
Mascalchi M, Picozzi G, Puliti D, Diciotti S, Deliperi A, Romei C, et al.
Diagnostics (Basel)
. 2023 Jul;
13(13).
PMID: 37443590
The ITALUNG trial started in 2004 and compared lung cancer (LC) and other-causes mortality in 55-69 years-aged smokers and ex-smokers who were randomized to four annual chest low-dose CT (LDCT)...
7.
Visioli C, Rossi P, Armaroli P, Iossa A, Rizzolo R, Bonelli L, et al.
J Med Screen
. 2023 Mar;
30(3):142-149.
PMID: 36999190
Objective: To evaluate the association between human papillomavirus vaccination status and participation in cervical cancer screening (at age 25) by the first cohorts of girls who were offered vaccination at...
8.
Pisano L, Grandi V, Tiradritti L, Zuccati G, Caminati F, Giani I, et al.
Sex Transm Dis
. 2022 Jun;
49(9):622-627.
PMID: 35687884
Background: The objective of this study was to evaluate the performance of a combined approach of liquid-based anal cytology and human papillomavirus (HPV) testing in predicting patients who should undergo...
9.
Rossi P, Ronco G, Mancuso P, Carozzi F, Allia E, Bisanzi S, et al.
Int J Cancer
. 2022 May;
151(7):1047-1058.
PMID: 35579975
As the primary screening test, E6/E7 mRNA has shown similar sensitivity for CIN3+ and lower positivity rate than the HPV DNA test. Nevertheless, the overall mRNA positivity is too high...
10.
Paganini I, Sani C, Chilleri C, Baccini M, Antonelli A, Bisanzi S, et al.
Infect Dis (Lond)
. 2022 Mar;
54(7):478-487.
PMID: 35239458
Background: SARS-CoV-2 pandemic represented a huge challenge for national health systems worldwide. Pooling nasopharyngeal (NP) swabs seems to be a promising strategy, saving time and resources, but it could reduce...